Skip to main content
OpenTrials

Clinical trial condition

Motor Neuron Disease

Explore clinical trials studying Motor Neuron Disease. Study availability and eligibility vary by location and protocol.

158 public trials 39 recruiting studies
Refine in advanced search Browse all conditions

Motor Neuron Disease trial results

Recruiting

Spastic Paraplegia - Centers of Excellence Research Network

NCT06553976

Conditions
Congenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Early Onset Hereditary Spastic Paraplegia, +18 more
Locations
  • University of Miami Miller School of Medicine Miami, Florida, United States
  • University of Iowa Carver College of Medicine Iowa City, Iowa, United States
  • Boston Children's Hospital Boston, Massachusetts, United States
  • Massachusetts General Hospital Boston, Massachusetts, United States
View Trial Details
Recruiting

Translating Single-cell Vulnerability Into Novel ALS Biomarkers and Therapeutic Targets: Towards a Liquid Nerve Biopsy

NCT07268833

Conditions
Amyotrophic Lateral Sclerosis, Amyotrophic Lateral Sclerosis (ALS), Central Nervous System Diseases, +14 more
Locations
  • Azienda Ospedaliero Universitaria di Cagliari Monserrato, California, Italy
  • Fondazione IRCCS Istituto Neurologico Carlo Besta Milan, Italy
  • IRCCS Ospedale San Raffaele SRL Milan, Italy
  • Azienda Ospedaliera Universitaria Federico II Naples, Italy
View Trial Details
Recruiting

Imaging Biomarkers in ALS

NCT02567136

Conditions
Amyotrophic Lateral Sclerosis, Central Nervous System Diseases, Metabolic Diseases, +9 more
Locations
  • University of Minnesota Minneapolis, Minnesota, United States
View Trial Details
Recruiting

Target ALS Biomarker Study; Longitudinal Biofluids, Clinical Measures, and At Home Measures

NCT05137665

Conditions
Amyotrophic Lateral Sclerosis, Central Nervous System Diseases, Degenerative Disorder, +10 more
Locations
  • Barrow Neurological Institute Phoenix, Arizona, United States
  • University of California San Diego San Diego, California, United States
  • Georgetown University Georgetown, District of Columbia, United States
  • Mayo Clinic Jacksonville, Florida, United States
View Trial Details
Recruiting

Efficacy and Safety of Masitinib Versus Placebo in the Treatment of ALS Patients

NCT03127267

Conditions
Amyotrophic Lateral Sclerosis, Central Nervous System Diseases, Metabolic Diseases, +8 more
Locations
  • University of Alabama at Birmingham Birmingham, Alabama, United States
  • University of Southern California Los Angeles, California, United States
  • University of Kentucky Lexington, Kentucky, United States
  • Johns Hopkins Medicine Brain Science Institute Baltimore, Maryland, United States
View all 56 locations
View Trial Details

Related conditions